203 related articles for article (PubMed ID: 16495378)
1. Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure.
Pfab T; Thöne-Reineke C; Theilig F; Lange I; Witt H; Maser-Gluth C; Bader M; Stasch JP; Ruiz P; Bachmann S; Yanagisawa M; Hocher B
J Am Soc Nephrol; 2006 Apr; 17(4):1082-9. PubMed ID: 16495378
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelin ETB receptor in partial ablation-induced chronic renal failure in rats.
Okada Y; Nakata M; Izumoto H; Takasu M; Tazawa N; Takaoka M; Gariepy CE; Yanagisawa M; Matsumura Y
Eur J Pharmacol; 2004 Jun; 494(1):63-71. PubMed ID: 15194452
[TBL] [Abstract][Full Text] [Related]
3. Extrarenal ETB plays a significant role in controlling cardiovascular responses to high dietary sodium in rats.
Ohkita M; Wang Y; Nguyen ND; Tsai YH; Williams SC; Wiseman RC; Killen PD; Li S; Yanagisawa M; Gariepy CE
Hypertension; 2005 May; 45(5):940-6. PubMed ID: 15809364
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
5. Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes.
Hartner A; Cordasic N; Klanke B; Wittmann M; Veelken R; Hilgers KF
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F820-7. PubMed ID: 17018847
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
[TBL] [Abstract][Full Text] [Related]
7. Urinary protein profiling with surface-enhanced laser desorption/ionization time-of-flight mass spectrometry in ETB receptor-deficient rats.
Raila J; Kalk P; Pfab T; Thöne-Reineke C; Godes M; Yanagisawa M; Schweigert FJ; Hocher B
Can J Physiol Pharmacol; 2008 Aug; 86(8):566-70. PubMed ID: 18758505
[TBL] [Abstract][Full Text] [Related]
8. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
Hill JV; Findon G; Appelhoff RJ; Endre ZH
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F837-44. PubMed ID: 20660017
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
10. Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats.
Sullivan JC; Pollock JS; Pollock DM
Exp Biol Med (Maywood); 2006 Jun; 231(6):818-23. PubMed ID: 16741005
[TBL] [Abstract][Full Text] [Related]
11. Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats.
Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K; Nakahori Y
J Endocrinol; 2009 Jan; 200(1):53-61. PubMed ID: 18931022
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of endothelin B receptors and mechanical hyperalgesia in experimental chronic diabetes.
Berti-Mattera LN; Gariepy CE; Burke RM; Hall AK
Exp Neurol; 2006 Oct; 201(2):399-406. PubMed ID: 16806184
[TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.
Neuhofer W; Pittrow D
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747
[TBL] [Abstract][Full Text] [Related]
14. Increased aldosterone levels in a model of type 2 diabetes mellitus.
Fredersdorf S; Endemann DH; Luchner A; Heitzmann D; Ulucan C; Birner C; Schmid P; Stoelcker B; Resch M; Muders F; Riegger GA; Weil J
Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):15-20. PubMed ID: 18726873
[TBL] [Abstract][Full Text] [Related]
15. Rodent models of streptozotocin-induced diabetic nephropathy.
Tesch GH; Allen TJ
Nephrology (Carlton); 2007 Jun; 12(3):261-6. PubMed ID: 17498121
[TBL] [Abstract][Full Text] [Related]
16. The effect of flutamide on systemic and renal hemodynamics in Zucker diabetic rats: paradoxic renal vasodilator response to endothelin-1 and TXA2 receptor activation in female sex.
Ajayi AA; Fidelis P
J Cardiovasc Pharmacol; 2006 Nov; 48(5):191-8. PubMed ID: 17110800
[TBL] [Abstract][Full Text] [Related]
17. Low NaCl intake elevates renal medullary endothelin-1 and endothelin A (ETA) receptor mRNA but not the sensitivity of renal Na+ excretion to ETA receptor blockade in rats.
Klinger F; Grimm R; Steinbach A; Tanneberger M; Kunert-Keil C; Rettig R; Grisk O
Acta Physiol (Oxf); 2008 Mar; 192(3):429-42. PubMed ID: 17892519
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of Liuwei Dihuang decoction on early diabetic nephropathy induced by streptozotocin via modulating ET-ROS axis and matrix metalloproteinase activity in rats.
He H; Yang X; Zeng X; Shi M; Yang J; Wu L; Li L
J Pharm Pharmacol; 2007 Sep; 59(9):1297-305. PubMed ID: 17883901
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelin in human hypertension.
Touyz RM; Schiffrin EL
Can J Physiol Pharmacol; 2003 Jun; 81(6):533-41. PubMed ID: 12839265
[TBL] [Abstract][Full Text] [Related]
20. Effects of transgenic endothelin-2 overexpression on diabetic cardiomyopathy in rats.
Liefeldt L; Rylski B; Walcher F; Manhart J; Kron S; Rosenke YW; Paul M; Neumayer HH; Amann K; Peters H
Eur J Clin Invest; 2010 Mar; 40(3):203-10. PubMed ID: 20100233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
